(MD) 2nd degree connection2nd CMO Impel NeuroPharm
As CMO to several successive west coast based biotech companies, two of which I have helped take public, I have experience of both private and public executive issues and challenges. I am used to setting aggressive timelines with novel drugs (small molecule NCEs, therapeutic oligonucleotides and new inhaled aerosolized formulations of old systemic drugs), and executing multiple clinical programs in parallel with small teams plus heavy reliance on outsourced support. I have significant experience designing, writing, leading and monitoring preclinical and clinical research studies (Phase I, II, III and IV) in multiple disease areas for different size companies (as employee or consultant); building departments (clinical operations & execution; medical & regulatory affairs; project management, clinical contracting & quality assurance) as well as downsizing or relocating operations; key opinion leader development; Advisory Board planning and execution; publications (strategizing and executing); testing-the-waters and IPO roadshows and subsequent investor relations follow up; business development support with in/out-licensing support and due diligence.
building departments (clinical operations & execution; medical & regulatory affairs; project management, clinical contractin